Boothbay Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Boothbay Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,100	Closed	-$505K	–	2017
2022 Q3	$505K	Buy	7,100 +4,100	+137%	+$297K	0.01%	1226
2022 Q2	$231K	Sell	3,000 -7,000	-70%	-$533K	0.01%	1637
2022 Q1	$730K	Sell	10,000 -6,500	-39%	-$436K	0.02%	1093
2021 Q4	$1.03M	Buy	+16,500	New	+$968K	0.02%	734
2020 Q4	–	Sell	-337	Closed	-$2.03M	–	1238
2020 Q3	$2.03M	Buy	+337	New	+$20.3K	0.12%	223
2019 Q2	–	Sell	-3,025	Closed	-$14.4M	–	750
2019 Q1	$14.4M	Buy	3,025 +2,577	+575%	+$128K	1.4%	7
2018 Q4	$2.33M	Hold	448	–	–	0.34%	57
2018 Q3	$2.78M	Hold	448	–	–	0.27%	79
2018 Q2	$2.48M	Sell	448 -404	-47%	-$21.8K	0.22%	85
2018 Q1	$5.39M	Buy	+852	New	+$54.8K	0.64%	33

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boothbay Fund Management's BMY Position: Q2 2026 in Review

Boothbay Fund Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $329K and bringing the position to 60,305 shares worth $3.47M. The position accounts for 0.05% of the portfolio, ranked #462.

Boothbay Fund Management first reported a position in BMY in Q1 2016 and has held it in 26 quarters since. The position peaked at $5.13M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Boothbay Fund Management held 60,305 shares of Bristol-Myers Squibb worth $3.47M as of Q2 2026.
Boothbay Fund Management bought 5,738 Bristol-Myers Squibb shares in Q2 2026, an estimated $329K.
Bristol-Myers Squibb made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #462 holding.
Boothbay Fund Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 26 quarters since.
Boothbay Fund Management's Bristol-Myers Squibb position peaked at $5.13M in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.